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Abstract 
Lineage 2 West Nile virus (WNV) strains were reported for the first time in Europe in 2004. Despite an almost silent 
circulation around their entry point in Hungary, an upsurge of pathogenicity occurred in 2010 as 262 people suffered 
from neuroinvasive disease in Greece. This increase in virulence was imputed to the emergence of a His249Pro muta-
tion in the viral NS3 helicase, as previously evidenced in American crows experimentally infected with the prototype 
lineage 1 North-American WNV strain. However, since 2003, WNV strains bearing the NS3Pro genotype are regularly 
isolated in Western-Mediterranean countries without being correlated to any virulent outbreak in vertebrates. We thus 
sought to evaluate the weight of the NS3249Pro genotype as a virulence marker of WNV in an in vivo avian model of 
WNV infection. We therefore characterized three genetically-related Eastern-Europe lineage 2 WNV strains in day-old 
specific pathogen-free (SPF) chickens: Hun2004 and Aus2008 which are both characterized by a NS3249His genotype, 
and Gr2011 which is characterized by a NS3249Pro genotype. Unlike Hun2004 and Aus2008, Gr2011 was weakly virulent 
in SPF chicks as Gr2011-induced viremia was lower and waned quicklier than in the Hun2004 and Aus2008 groups. 
Overall, this study showed that the presence of a proline residue at position 249 of the viral NS3 helicase is neither suf-
ficient nor necessary to confer pathogenicity to any given lineage 2 WNV strain in birds.
© 2015 Dridi et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
West Nile virus (WNV) is a mosquito-borne, posi-
tive sense, single-stranded RNA virus that belongs to 
the Flavivirus genus (Flaviviridae family), and that falls 
within the Japanese encephalitis virus antigenic complex 
[1]. WNV is maintained in a bird-arthropod cycle, with 
mosquitoes of the Culex genus representing its main 
vector, and wild birds the principal hosts [2, 3]. Never-
theless, incidental infections of reptiles, amphibians and 
mammals are also described, with humans and equines 
being the most susceptible to the disease [1, 4].
Phylogenetic studies of pathogenic WNV strains seg-
regate the isolates in two main lineages: lineage 1, which 
is composed of WNV strains from Europe, the Mid-
dle East, North America, Africa, Eastern Asia and Aus-
tralia, and lineage 2, which contains strains historically 
isolated in sub-Saharan Africa and Madagascar and that 
were initially considered non-pathogenic in humans 
and horses [5, 6]. Nevertheless, in 2004, a WNV strain 
related to Central African lineage 2 viruses was isolated 
from a sick goshawk (Accipiter gentilis) in Hungary, and 
WNV-induced encephalitis was diagnosed in two extra 
goshawks and two sparrow hawks (Accipiter nisus) in 
2005 [7]. Until 2007, sporadic cases were diagnosed in 
Hungary in wild birds, sheep, horses and humans, but 
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between 2008 and 2009, lineage 2 WNV quickly spread 
westward to neighboring Austria, and was responsible 
in both countries for an increased mortality for raptors 
and disease involving the central nervous system (CNS) 
in 18 horses and 22 humans [8–10]. A lineage 2 Hungar-
ian isolate from 2010 was further experimentally char-
acterized in intraperitoneally-inoculated C57BL/6 mice 
where it exhibited low LD50 values (10−0.48 TCID50) 
and high RNA loads in the brain [11]. The Austro-Hun-
garian lineage 2 virus subsequently spread southward to 
the Thessaloniki Greek region where an impressive WN 
neuroinvasive disease (WNND) epidemic broke out in 
humans in 2010, affecting 262 people amongst which 
34 succumbed [12, 13]. The same year, the first human 
outbreak of neuroinvasive disease due to a lineage 2 
WNV was reported in Romania [14]. This outbreak was 
caused by a strain that was highly similar to a Volgograd 
lineage 2 strain involved in an outbreak in Russia in the 
Volga Delta area in 2007, but is unrelated to the Greek-
Hungarian lineage 2. For this reason, lineage 2 WNV 
strains are supposed to have been introduced in Europe 
from Africa in at least two independent occasions [15]. 
In 2011, a lineage 2 WNV strain related to the Hungar-
ian-Greek strains was reported for the first time in a 
dead Eurasian collared dove (Streptopelia decaocto) and 
in Culex pipiens mosquitoes in North-Eastern Italy and 
also in at least two febrile patients from Central Italy and 
Sardinia [16–18] and caused at least 7 human cases of 
WNND in 2013 in the Po river area [19–21]. WNV line-
age 2 strains related to the Greek-Hungarian cluster have 
more recently spread to Serbia, where a large human 
outbreak occurred in 2012 [22, 23]. Finally, four lineage 
2 isolates closely related to the Austrian, Italian and Ser-
bian strains reported in 2008, 2011 and 2012 respectively, 
were detected in mosquitoes in the Czech Republic dur-
ing 2013 [24].
The Eastern-European lineage 2 WNV strain respon-
sible for the major human outbreak that took place in 
Greece in 2010 was characterized by the presence of a 
NS3249Pro genotype [13, 19]. Similarly, the most severe 
European and Mediterranean WNV epidemics caused by 
lineage 1 WNV strains (Romania in 1996, Israel in 1998 
and Volgograd in 1999) were also due to strains bear-
ing the NS3249Pro genotype [25, 26]. Moreover, the vast 
majority of WNV strains isolated in North America—
where WNND took its heaviest toll worldwide—are char-
acterized by a NS3249Pro genotype [27]. This association 
between enhanced pathogenicity for birds and humans 
and the NS3249Pro genotype led to proposing this muta-
tion as a molecular determinant of WNV pathogenicity. 
Experimentally, birds are the only hosts so far where the 
NS3249Pro substitution was demonstrated to be a viru-
lence marker of WNV by means of mutational analyses 
using the genetic backbone of the prototype North-
American lineage 1 WNV strain NY99 [25]. Indeed, 
American crows (Corvus brachyrhynchos) and House 
sparrows (Passer domesticus) exhibited higher viral loads 
and/or mortality rates when position 249 of the NS3 was 
occupied by a proline residue rather than by a threo-
nine, alanine or asparagine, while 3 week-old CD-1 mice 
showed comparable LD50 values and neurovirulence 
phenotypes no matter the inoculated variant [25, 26]. 
Importantly, since 2003, lineage 1 WNV strains bearing 
the NS3249Pro genotype are regularly isolated from West-
ern-Mediterranean countries, like Italy, Spain and Portu-
gal, without being correlated to any significant virulent 
outbreaks in humans, horses, nor birds, or inducing an 
enhanced pathogenicity in experimentally infected birds 
and mice [28–30].
On the one hand, if WNV E protein glycosylation on 
residue 154 clearly appears as being an undeniable and 
versatile virulence determinant of WNV that enhances 
infection in birds as well as in mice and Culex mosquito 
species [31–36], the presence of a proline residue at posi-
tion 249 of the viral NS3 helicase is so far ambiguous as of 
its role in increasing WNV virulence in any given WNV 
strain. On the other hand, SPF chickens aged 1  day at 
the time of an experimental inoculation with WNV were 
previously shown to represent a sensitive avian model for 
WNV infection as well as a reliable tool for pathotyping 
epidemiologically different WNV strains [37]. Therefore, 
we sought to compare the pathogenicity of genetically 
close lineage 2 WNV strains (the Hungarian Hun2004, 
the Austrian Aus2008 and the Greek Gr2011) that bear 
differing residues at position NS3249 (proline or histidine) 
[19] in a SPF chicken model for WNV infection. The aims 
of this study were to investigate whether (1) three line-
age 2 West Nile virus strains associated to different epi-
demiologies in the field would elicit different pathotypes 
in the day-old SPF chicken infection model, and whether 
(2) this in vivo characterization would infirm or confirm 
the NS3249Pro genotype as a virulence marker of lineage 2 
West Nile virus strains.
Materials and methods
Viruses and virus preparations
Lineage 2 WNV strains Hun2004 (genotype NS3249His, 
Genbank accession no: DQ116961.1), Aus2008 (geno-
type NS3249His, Genbank accession no: KF179640.1) and 
Gr2011 (genotype NS3249Pro, Genbank accession no: 
JN398476.2) were used. The inocula were prepared by 
amplification in Vero cells (African green monkey kid-
ney-derived cells, provided by P. Desprès from the Pas-
teur Institute of Paris), for 2 passages for Hun2004 and 
Aus2008, and for 3 passages for Gr2011. Infected cells 
were analyzed by a freeze–thaw cycle after each passage 
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and both virus-containing cell lysates and supernatants 
were frozen and stored in aliquots at −80 °C.
One aliquot from each amplified virus was used to 
titrate the strains using the TCID50 titration method [37]. 
TCID50/mL values were calculated according to the Reed 
and Muench method [38].
Chickens
After hatching, SPF white Leghorn chickens provided 
by Lohmann Valo (Cuxhaven, Germany) were kept in 
biosecurity level 3 (BSL-3) isolators and animal experi-
ments were conducted under the authorization and 
supervision of the Biosafety and Bioethics Committees 
at the Veterinary and Agrochemical Research Institute, 
following National and European regulations (proce-
dure agreement no 111202-01). The birds were provided 
with a commercial diet for poultry and water ad libitum 
throughout the experiments.
Experimental inoculations
In independent experiments, SPF chickens were inocu-
lated subcutaneously (100 µL inoculum/chick) in the cer-
vical region at the age of 1 day with a dose of 103 TCID50 
of West Nile virus diluted in sterile PBS. The dose of 103 
TCID50 was chosen because it is close to the dose usu-
ally inoculated by C. pipiens mosquitoes during natural 
infections (i.e. 104.3 PFU, [39]), and because we showed 
in a previous work [37] that this dose allows a significant 
discrimination between different pathotypes of lineage 1 
West Nile virus strains in the SPF chicken model, based 
on mortality rates. The number of inoculated chicks 
amounted to 52 for Hun2004, 51 for Aus2008 and 42 for 
Gr2011. On 2, 5, 7, 9, 12 and 14 days post-infection (dpi), 
5 chickens per sub-group were sacrificed by exsanguina-
tion. Blood was immediately collected in microtubes and 
allowed to clot for 6 h at room temperature (RT°). After 
centrifugation at 2345 g for 5  min, serum was collected 
and aliquots stored at −20 or −80  °C for further deter-
mination of neutralizing antibodies titers or RNA extrac-
tion, respectively. Two to three wing primary feathers 
were sampled from every sacrificed bird and stored in 
600  µL of RNA later (RNA Stabilization Reagent, Qia-
gen Benelux B.V., The Netherlands) at −80 °C for further 
RNA extraction.
Viremia monitoring
RNA was extracted from sera samples using a QIAamp 
Viral RNA Mini Kit (Qiagen Benelux B.V., Venlo, The 
Netherlands) according to the manufacturer’s instruc-
tions. RNA was recovered in 60  µL elution buffer (pro-
vided by the manufacturer) and stored at −80 °C. Two µL 
of each extract, in 25  µL final volume, were subjected 
to rRT-PCR amplification using the QuantiTect Probe 
RT-PCR Kit (Qiagen GmBh, Hilden, Germany) and fol-
lowing manufacturer’s instructions. The mix included 
primers (WNNS2-F: 5′-CCTTTTCAGTTGGGCCTT 
CTG-3′ and WNNS2a-R: 5′-GATCTTGGCTGTCCACC 
TCTTG-3′) at 0.15 µM final concentration, and a FAM-
labeled TAMRA probe (WNNS2A-6-FAM TAMRA: 
5′-TTCTTGGCCACCCAGGAGGTC-3′-TAMRA) at 
0.2  µM final concentration. Amplification conditions 
consisted of a first reverse-transcription step at 50 °C for 
30 min, followed by 10 min at 95 °C and 50 cycles of 15 s 
at 95  °C, 34  s at 54  °C and 10  s at 72  °C, as previously 
described [37]. Quantitation of WNV RNA copy number 
was calculated by generating standard curves with serial 
dilutions of quantified WNV NS2a synthetic RNA.
Viral genome detection in feathers
Feathers were prepared by homogenization for 6  min 
at 30 cycles/s in 600  µL of Ambion® MagMAX™ 
Lysis⁄Binding Solution Concentrate (Life Technologies 
Europe B.V., Gent, Belgium) 0.04 M DTT using a Tissue-
Lyzer™ homogenizer (Qiagen, Venlo, The Netherlands) 
and in presence of a 5 mm Ø stainless steel bead. After 
clarification at 8000 rpm for 10 min, RNA was extracted 
using a MagMAX™-96 Total RNA Isolation Kit (Life 
Technologies Europe B.V., Gent, Belgium) according to 
the manufacturer’s instructions. RNA was recovered in 
50  µL of elution buffer (provided by the manufacturer) 
and stored at −80 °C. Two µL of each extract were sub-
jected to the NS2a-specific rRT-PCR in 25  µL final 
volume.
Neutralizing antibody titers determination
β-seroneutralization (SN) allows the titration of the neu-
tralizing antibodies present in a serum by diluting the lat-
ter while keeping a constant concentration of virus. The 
diluted serum and the constant dose of virus are brought 
into contact with competent cells that are then plated 
in a multiwell plate. The neutralizing antibodies titer is 
deduced from the last serum dilution where the com-
petent cells do not show cytopathic effects (CPE). Every 
serum sample was inactivated during 30  min at 56  °C 
and tested in duplicate. Sera were subjected to a series 
of threefold dilutions beginning from a 1/5 dilution in 
DMEM High Glucose Pyruvate solution (Life Technolo-
gies Europe B.V., Belgium) supplemented with 5.6 mg/L 
of Tylosin Solution (Sigma-Aldrich, Steinheim, Germany) 
in a final volume of 50 µL, and were subsequently trans-
ferred to a flat bottom 96-well plate (Nuncleon Delta 
Surface, Thermo Fischer Scientific, Roskilde, Denmark). 
102 TCID50/mL of the WNV strain used for experimen-
tal inoculation, in a volume of 50 µL, were then added in 
every serum-containing well. After 1  h 30  min of incu-
bation at 37 °C under 5% CO2, 100 µL of a 1/20 dilution 
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of freshly passaged Vero cells were added to every well. 
After three further days of incubation at 37 °C under 5% 
CO2, wells were visually assessed for the development 
of cytopathic effects, and the mean titer in neutralizing 
antibodies was calculated for every serum sample.
Statistical analysis
Statistical analyses of data were performed using Minitab 
13 and STATA 10 software (statistical programs for Win-
dows 2000) and differences were considered significant at 
P < 0.05.
For each dpi, viremia values after inoculation with 
Hun2004, Aus2008 and Gr2011 were compared. After 
checking the validity hypotheses (normality of the criterion 
distribution for each group by the Ryan–Joiner test and 
homogeneity of the within-groups’ variances by the Lev-
ene test), ANOVA and Tukey’s pairwise comparison tests 
were used for comparison of the three Hun2004, Aus2008 
and Gr2011 groups. When normality or homogeneity of 
variance tests failed, the non-parametric Mann–Whit-
ney test on the one hand, and Kruskal–Wallis test on the 
other hand, were used. Similar statistical analyses were 
performed on the detection of neutralizing antibodies in 
serum and NS2a RNA in feathers in order to compare the 
three sets of inoculated groups at different dpi.
Results
Virological characterization
SPF chickens were inoculated subcutaneously at the age 
of 1 day with a dose of 103 TCID50 of Hun2004, Aus2008 
or Gr2011 and experimental follow-up was carried out 
for 14 dpi. Viremia—as measured by the log of NS2a 
RNA copies/µL—was detectable from 2 to 9 dpi and from 
to 2 to 7 dpi after inoculation of chickens with Hun2004 
and Aus2008 strains respectively (Figure  1A). Viremia 
peaked at 2 dpi whatever the viral strain, and decreased 
steadily all over the detection period. However, Gr2011 
induced a detectable viremia only on 2  dpi. Viremia 
Figure 1 Viral RNA loads follow-up in sera and feathers after infection with lineage 2 WNV strains. Mean viral loads in sera A and feathers 
B were estimated by NS2a-specific rRT-PCR in day-old SPF chicks experimentally inoculated with either Hun2004 (black bars), Aus2008 (hatched 
bars) or Gr2011 (white bars). Error bars represent the standard error of the mean. Above the bars, numbers of positives/examined samples are 
indicated. *P < 0.05 for Hun2004 and Aus2008 versus Gr2011 at 2 dpi. #P < 0.05 for Hun2004 versus Aus2008 versus Gr2011 at 5 dpi. $P < 0.05 for 
Aus2008 versus Gr2011 at 2 dpi. &P < 0.05 for Aus2008 versus Hun2004 and Gr2011 at 14 dpi. NS2a-specific rRT-PCR detection limit is 101.67 RNA 
copies/µL.
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evolution profiles did not only differ in duration but also 
in amplitude, as viremia at 2 dpi was significantly higher 
(p  <  0.05) in the Hun2004 and Aus2008 groups than in 
the Gr2011 group. Moreover, at 5 dpi, the Aus2008 group 
had the highest viremia (p < 0.05) while the Gr2011 had 
the lowest viremia (p < 0.05). Overall, the viral load was 
statistically significantly higher (p < 0.05) in the Aus2008 
and Hun2004 groups than in the Gr2011 group.
In feathers, viral genome was detectable all over the 
infection period, from 2 to 14 dpi for both Hun2004 and 
Aus2008 viral strains (Figure 1B). In chickens inoculated 
with Gr2011, viral load in feathers was also detectable up 
to 14  dpi, but the rRT-PCR gave positive results begin-
ning from 5  dpi only. With the three viral strains, RNA 
detection in feathers reached a peak at 5  dpi, and only 
slightly decreased over the infection. Overall, Aus2008 
elicited significantly higher (p < 0.05) viral loads in feath-
ers than Gr2011 all over the infection period. Moreover, 
when data were examined dpi by dpi, Aus2008 elicited 
significantly higher (p < 0.05) viral loads in feathers than 
Gr2011 at 2 dpi, and than Hun2004 and Gr2011 at 14 dpi.
Serological characterization
The three lineage 2 WNV strains induced seroconver-
sion in the inoculated chicks (Figure  2). Neutralizing 
antibodies were first detected in chickens inoculated 
with Hun2004 and Gr2011, at 5 dpi, and then in chicks 
infected with Aus2008, at 7  dpi. The overall humoral 
response was amplest in chicks of the Hun2004 group, 
but this difference was not statistically significant.
Discussion
We have compared in this study the pathogenic profile of 
related lineage 2 WNV strains bearing either a NS3249Pro 
or a NS3249His genotype, while previous studies dealing 
with NS3249 polymorphism usually compared NS3249Pro 
genotype with NS3249Thr genotype [25, 28, 30, 40]. We 
have shown that despite its NS3249Pro genotype, Gr2011 
was weakly pathogenic in a SPF chicken model of WNV 
infection. Indeed, Gr2011-induced viremia was lower 
and waned quicklier than in the Hun2004 and Aus2008 
groups. The study by Langevin et  al. [26] has shown 
that even if the scientific literature tends to oppose the 
NS3249Pro genotype against all the other existing NS3249 
polymorphisms, the alternative residues alanine, thre-
onine, histidine and asparagine are not equally less 
efficient than proline in enhancing virulence in experi-
mental settings [26]. Thus, at least in vitro and in Ameri-
can crows, a histidine residue at position 249 of the NS3 
of the North-American lineage 1 prototype strain NY99 
is less efficient than a threonine residue at decreasing its 
initial virulence, which is due to its NS3249Pro genotype. 
This has also been shown through our experimental 
inoculations of SPF chickens with three lineage 2 WNV 
strains which either bear a NS3249His genotype (Hun2004 
and Aus2008) or a NS3249Pro genotype (Gr2011). These 
strains belong to the Greek-Hungarian cluster of lineage 
2 WNVs [8]. Moreover, Hun2004 and Aus2008 strains 
are 99% identical with regards to their nucleotide as 
well as to their amino-acid sequences [8]. Aus2008 and 
Hun2004 are both characterized by a NS3249His genotype, 
and they only diverge as of four residues located in the 
E, NS1, NS2a and NS5 viral proteins [19] (Table  1). In 
accordance with their NS3249His genotype, Aus2008 and 
Hun2004 were both virulent in the SPF chicken model. 
Aus2008 was experimentally inoculated by Del Amo 
et  al., to House sparrows (P. domesticus) which compa-
rably developed detectable viremia from 1 to 5 dpi with 
a peak at 3  dpi [40]. Moreover, an experimental infec-
tion study using an Austrian lineage 2 WNV isolate from 
2009 showed that one-third of the assayed large falcons 
(Falco rusticolus, and F. rusticolus × F. cherrug and F. rus-
ticolus ×  F. peregrinus hybrids) succumbed to the virus 
while all the birds developed viremia and shed virus [41]. 
The pathogenicity of Hun2004 and Aus2008 for chickens 
Figure 2 Neutralizing antibodies titers follow-up after infec-
tion with lineage 2 WNV strains. Mean neutralizing antibodies 
titers over days post-infection were estimated by β-seroneutralization 
tests in day-old SPF chicks experimentally inoculated with either 
Hun2004 (black bars), Aus2008 (hatched bars) or Gr2011 (white bars) 
lineage 2 WNV strains. Error bars represent the standard error of the 
mean. Above the bars, numbers of positives/examined samples are 
indicated.
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evidenced the fact that the presence of a proline residue 
at position 249 of the NS3 helicase is not necessary for 
a given WNV isolate to be virulent in infection models. 
Indeed, unrelated lineage 1 strains that bear a threonine 
instead of a proline at position 249 of the NS3 have also 
been associated with deadly epidemics in humans and 
horses in Tunisia, Italy, France and Spain in respectively 
1997, 1998 and 2008, 2000 and 2010 [5, 25, 42–44].
The Gr2011 strain is directly derived from and geneti-
cally almost identical to the Nea Santa-Greece-2010 
strain responsible for the dramatic 2010 Greek human 
epidemic [45–47]. Even though Hun2004 and Aus2008 
are genetically highly related to their Greek progeny 
strains Gr2011 and Nea Santa-Greece-2010, the Greek 
strains cluster in a distinct phylogenetic group and 
are characterized by a NS3His249Pro substitution [46]. 
Although the experimental infection of European Jack-
daws (Corvus monedula) showed a high sensitivity of the 
assayed birds to a lineage 2 strain circulating in 2010 in 
Greece [48], notable avian mortalities associated with the 
Greek lineage 2 isolates were absent in the field. Accord-
ingly, Gr2011 was in this study the least virulent strain in 
the SPF chicken infection model. Gr2011 indeed elicited 
only a low and short-term viremia (detection limited to 
2 dpi). This observation, in addition to the association of 
lineage 2 Greek strains with human WNND cases, high-
lights the fact that avian WNV infection models might 
be predictive of the pathotype of a given WNV in birds 
only, and not in mammalian hosts. Nevertheless, given 
the central role of birds in amplifying and transmitting 
WNV to potential ornithophilic or bridge vectors, their 
susceptibility to be infected by a given WNV strain and 
to develop high-titer viremia following infection is posi-
tively correlated to their ability to spread the virus in an 
enzootic and zoonotic manner [49]. Of note, despite gen-
eral low virulence, Gr2011 induced detectable viremia in 
SPF chicks at 2 dpi, underlining its potential amplifica-
tion and spread in avian hosts.
In our hands, WNV RNA was detected in the feathers 
of all three experimental groups infected with Hun2004, 
Aus2008 or Gr2011 up to the end of the observation 
period (i.e., 14 dpi). This slower clearance of WNV from 
the feathers compared to serum was previously observed 
in the SPF chickens [37]. Nevertheless, the levels of 
detected viral RNA loads in the feathers still correlated 
with viremia levels. Indeed, viral RNA loads in the feath-
ers of the Aus2008 group were significantly highest over 
the whole infection period, while viremia of the same 
group showed the highest peak at 5 dpi. Moreover, viral 
RNA load detection in the feathers of the GR2011 group 
was delayed to 5 dpi, while viremia in this group waned 
the fastest, as virus was detected in the serum of the 
GR2011 group only on 2 dpi.
The low virulence of Gr2011 for day-old SPF chicks 
in our hands highlighted the fact that the presence of a 
proline at position 249 of the NS3 helicase does not guar-
antee an enhanced virulence in a given infection model. 
Accordingly, an Italian strain isolated in 2012, also bear-
ing a proline in position 249 of NS3 and found to be 
exactly similar to Nea Santa-Greece-2010 after the align-
ment of their NS5 and NS3 partial sequences, was asso-
ciated with neither human nor veterinary cases in the 
region where the strain had been isolated [21]. By inoc-
ulating mice, red partridges (Alectoris rufa) and house 
sparrows (P. domesticus) with related strains bearing 
or not a NS3249Pro genotype, Del Amo et  al. and Sotelo 
et al. also came to the conclusion that a proline residue 
at position 249 of NS3 is neither sufficient nor necessary 
for WNV pathogenicity [28–30, 40]. Additionally, atten-
tion must be brought to the fact that Gr2011 not only dif-
fers from both Aus2008 and Hun2004 as of the residue 
at position 249 of NS3, but also at the level of residues 
located at positions 119 of NS2b and 14, 49 and 113 of 
NS4b (Table 1). Within Gr2011 genetic backbone, com-
plementarily to or independently from the NS3His249Pro 
substitution, one or more of these four additional sub-
stitutions might then be responsible for the loss of 
Table 1 Variant amino acids encoded by WNV lineage 2 genome sequences of Hun2004, Aus2008 and Gr2011
Residues that are unique to Gr2011 when compared to Hun2004 and Aus2008 are italicized. (Adapted from [19, 46] and from a personal communication from Sylvie 
Lecollinet and Céline Bahuon (Anses))
Genome sequence name (Genbank 
accession number)
Mature peptide
Amino acid position in mature peptide (Amino acid position in polyprotein)
E NS1 NS2a NS2b NS3 NS4b NS5
88 (378) 69 (860) 1 (1140) 119 (1493) 249 (1754) 14 (2287) 49 (2322) 113 (2386) 25 (2554)
Hun2004 (DQ116961) Ser Gly His Val His Ser Thr Val Ala
Aus2008 (KF179640) Pro Glu Tyr Val His Ser Thr Val Thr
Gr2011 (JN398476) Pro Glu Tyr Ile Pro Gly Ala Met Thr
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pathogenicity of Gr2011 for raptors [8] and SPF chickens, 
and/or for its increased virulence for humans compared 
to Hun2004 and Aus2008. Mutational analyses of NS2b, 
the co-factor of the NS3 protease and a protein impli-
cated in the formation of viral replication complexes [50–
52], are not described in the literature. However, such 
studies are available for NS4b. WNV NS4b co-localizes 
with other components of the viral replication complex, 
such as NS3 and double-stranded RNA [52] and is criti-
cal for the induction of paracrystalline arrays/convoluted 
membranes and vesicle packets allowing for replication, 
membrane complex formation and maturation of viral 
proteins [52–54]. Moreover, NS4b inhibits the interferon-
signaling cascade at the level of nuclear STAT phospho-
rylation [55]. Remarkably, NS4b has a highly conserved 
N-terminal motif (residues 35 through 60) among Fla-
viviruses and a central hydrophobic region (residues 95 
through 120). Substitutions brought simultaneously in 
the N-terminal domain and the central hydrophobic 
region of NS4b (Pro38Gly and Thr116Ile), or occurring 
in the central hydrophobic region alone (Cys102Ser) of 
a clone of NY99, correlated with an attenuated neuroin-
vasive phenotype in mice and a small plaque variant [56, 
57]. One could then speculate that at least one or both 
of the two NS4bThr49Ala and NS4bVal113Met substitutions, 
which occurred within Gr2011 strain in respectively the 
N-terminal and central hydrophobic region, could have 
modified the pathogenicity of Gr2011 when compared 
to Hun2004 and Aus2008, despite the presence of the 
NS3249Pro genotype. However, this hypothesis demands 
extensive experimental studies in various species to be 
evaluated.
We chose in this study to use SPF chickens as an infec-
tion model as in the particular context of West Nile dis-
ease, they belong to a taxon (Aves) that represents the 
natural reservoir of the virus. Moreover, SPF chickens 
as experimental animals present many advantages over 
other vertebrates as they are easy to breed, genetically 
homogeneous, and free from maternally-derived anti-
bodies and from specific pathogens and other underly-
ing diseases [58–60]. Finally, we have shown in a previous 
study that SPF chickens aged 1 day at the time of experi-
mental inoculation not only represent a sensitive avian 
model for WNV infection, but also allow the pathotyping 
of epidemiologically varying WNV strains [37].
In this study, we sought to demonstrate the extent to 
which the presence of a proline residue at position 249 of 
the viral NS3 helicase constitutes a determinant of viru-
lence for given European lineage 2 isolates with amino-
acid sequences differing in more than one location. On 
the one hand, it appeared that the presence of a proline 
residue at position 249 of the NS3 of the studied strains 
is not a necessary or sufficient determinant of virulence 
for SPF chickens. On the other hand, it seemed that the 
NS3249His substitution might not have such an attenuat-
ing effect on WNV virulence as the NS3249Thr residue. We 
indeed showed in the SPF chicken model that the two 
tested lineage 2 WNV strains bearing a Histidine at posi-
tion 249 of the NS3, namely Hun2004 and Aus2008, elic-
ited higher and longer-lasting viremias than the Gr2011 
strain bearing a Proline at position 249 of NS3. Moreover, 
our finding that the Gr2011 strain was the least virulent 
in the SPF chickens model despite its high virulence for 
humans highlighted the predictability of this avian model 
for pathogenicity in birds specifically, as Greek line-
age 2 WNV strains did not associate so far with notable 
bird mortalities in the field. This makes the SPF chicken 
model a promising surrogate for experimental inocula-
tions in wild birds.
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